US9174999, Table 1, Compound 7

ID: ALA3910350

Chembl Id: CHEMBL3910350

PubChem CID: 121486716

Max Phase: Preclinical

Molecular Formula: C30H58N9O5+

Molecular Weight: 624.85

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCC[N+](C)(C)CCCCCC(=O)NCCCCCCNC(=O)OC[C@@H]1NC(=N)N2CCC(O)(O)[C@@]23NC(=N)N[C@@H]13

Standard InChI:  InChI=1S/C30H57N9O5/c1-4-5-6-13-20-39(2,3)21-14-9-10-15-24(40)33-17-11-7-8-12-18-34-28(41)44-22-23-25-30(37-26(31)36-25)29(42,43)16-19-38(30)27(32)35-23/h23,25,42-43H,4-22H2,1-3H3,(H6-,31,32,33,34,35,36,37,40,41)/p+1/t23-,25-,30-/m0/s1

Standard InChI Key:  MHFQMZGWWBEMNU-VQGKEWTASA-O

Alternative Forms

  1. Parent:

    ALA3910350

    ---

Associated Targets(non-human)

Scn4a Sodium channel protein type IV alpha subunit (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 624.85Molecular Weight (Monoisotopic): 624.4555AlogP: 1.09#Rotatable Bonds: 20
Polar Surface Area: 194.92Molecular Species: BASEHBA: 7HBD: 9
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.76CX Basic pKa: 9.16CX LogP: -2.17CX LogD: -5.00
Aromatic Rings: Heavy Atoms: 44QED Weighted: 0.05Np Likeness Score: 0.87

References

1.  (2015)  Methods and compositions for studying, imaging, and treating pain, 

Source

Source(1):